Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,213 | 9,844 | 12,350 | 13,451 | 7,701 |
| Receivables | 687 | 625 | 675 | 366 | 419 |
| Inventories | 365 | 289 | 220 | 268 | 279 |
| Other current assets | 12 | 12 | 12 | 12 | 12 |
| TOTAL | $9,948 | $11,722 | $13,257 | $14,404 | $9,026 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 91 | 129 | 154 | 0 | 0 |
| TOTAL | $91 | $129 | $154 | $N/A | $N/A |
| Total Assets | $10,039 | $11,852 | $13,411 | $14,404 | $9,026 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,186 | 934 | 1,021 | 825 | 945 |
| Accrued Expenses | 400 | 591 | 717 | 529 | 412 |
| TOTAL | $1,678 | $1,655 | $1,878 | $1,353 | $1,357 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
| Other Non-Current Liabilities | 1,236 | 1,112 | 1,000 | 860 | 736 |
| TOTAL | $6,236 | $6,112 | $6,000 | $5,860 | $5,736 |
| Total Liabilities | $7,913 | $7,767 | $7,878 | $7,213 | $7,092 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 278 | 278 | 278 | 278 | 278 |
| Common Shares | 0 | 0 | 0 | 0 | 3 |
| Retained earnings | -117,890 | -115,647 | -113,844 | -111,830 | -109,597 |
| TOTAL | $2,126 | $4,085 | $5,533 | $7,191 | $1,934 |
| Total Liabilities And Equity | $10,039 | $11,851 | $13,411 | $14,404 | $9,026 |